B-CELL LYMPHOMA REFRACTORY
Clinical trials for B-CELL LYMPHOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA REFRACTORY trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough blood cancers in early trial
Disease control OngoingThis early-stage trial tests a new cell therapy called MB-CART19.1 in about 48 adults and children whose B-cell cancers (like leukemia or lymphoma) have come back or not responded to standard treatment. The therapy uses a patient's own immune cells, modified to better recognize a…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New hope for lymphoma patients: CAR T-Cell therapy as Second-Line treatment
Disease control OngoingThis study tests a treatment called axicabtagene ciloleucel (axi-cel) for people with aggressive B-cell lymphoma that has come back or not responded to treatment. Participants cannot have a standard stem cell transplant but are eligible for this CAR T-cell therapy. The goal is to…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated May 01, 2026 15:42 UTC